Friedrich M, Cermak T, Maderbacher P The effect of brochure use versus therapist teaching on patients performing therapeutic exercise and on changes in impairment status. Phys Ther. 1996 Oct;76(10):1082-8.
Hammer C, Degerfeldt L, Denison E Mechanical diagnosis and therapy in back pain: Compliance and social cognitive theory. Adv Physiother. 2007;9(4):190-197.
Härkäpää K, Järvikoski A, Mellin G, Hurri H A controlled study on the outcome of inpatient and outpatient treatment of low back pain. Part I. Pain, disability, compliance, and reported treatment benefits three months after treatment. Scand J Rehabil Med. 1989;21(2):81-9.
Holden MA, Haywood KL, Potia TA, Gee M, McLean S Recommendations for exercise adherence measures in musculoskeletal settings: a systematic review and consensus meeting (protocol). Syst Rev. 2014 Feb 10;3:10. doi: 10.1186/2046-4053-3-10.
Jordan JL, Holden MA, Mason EE, Foster NE Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005956. doi: 10.1002/14651858.CD005956.pub2. Review.
Khalil H, Quinn L, van Deursen R, Martin R, Rosser A, Busse M Adherence to use of a home-based exercise DVD in people with Huntington disease: participants' perspectives. Phys Ther. 2012 Jan;92(1):69-82. doi: 10.2522/ptj.20100438. Epub 2011 Sep 29.
Kramer A, Dettmers C, Gruber M Exergaming with additional postural demands improves balance and gait in patients with multiple sclerosis as much as conventional balance training and leads to high adherence to home-based balance training. Arch Phys Med Rehabil. 2014 Oct;95(10):1803-9. doi: 10.1016/j.apmr.2014.04.020. Epub 2014 May 10.
Marks R, Allegrante JP Chronic osteoarthritis and adherence to exercise: a review of the literature. J Aging Phys Act. 2005 Oct;13(4):434-60. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.